Chargement en cours...
Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
BACKGROUND: The carcinoma in situ (CIS) of urinary bladder is a flat, high-grade and aggressive manifestation of urothelial cancer which carries a great risk for progression to muscle invasive disease and metastatic spread. The aim of the study was to analyse the clinical history and survival differ...
Enregistré dans:
| Publié dans: | Transl Androl Urol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354324/ https://ncbi.nlm.nih.gov/pubmed/32676418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2020.03.40 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|